1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
2
|
Miller KD, Nogueira L, Mariotto AB,
Rowland JH, Yabroff KR, Alfano CM, Jemal A, Kramer JL and Siegel
RL: Cancer treatment and survivorship statistics, 2019. CA Cancer J
Clin. 69:363–385. 2019. View Article : Google Scholar : PubMed/NCBI
|
3
|
Stornello C, Archibugi L, Stigliano S,
Vanella G, Graglia B, Capalbo C, Nigri G and Capurso G: Diagnostic
delay does not influence survival of pancreatic cancer patients.
United European Gastroenterol J. 8:81–90. 2020. View Article : Google Scholar : PubMed/NCBI
|
4
|
Zhang J and Chen QM: Far upstream element
binding protein 1: A commander of transcription, translation and
beyond. Oncogene. 32:2907–2916. 2013. View Article : Google Scholar
|
5
|
Debaize L and Troadec MB: The master
regulator FUBP1: Its emerging role in normal cell function and
malignant development. Cell Mol Life Sci. 76:259–281. 2019.
View Article : Google Scholar
|
6
|
Frost JR, Mendez M, Soriano AM, Crisostomo
L, Olanubi O, Radko S and Pelka P: Adenovirus 5 E1A-Mediated
Suppression of p53 via FUBP1. J Virol. 92:e00439–18. 2018.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Rabenhorst U, Thalheimer FB, Gerlach K,
Kijonka M, Böhm S, Krause DS, Vauti F, Arnold HH, Schroeder T,
Schnütgen F, et al: Single-stranded DNA-binding transcriptional
regulator FUBP1 is essential for fetal and adult hematopoietic stem
cell self-renewal. Cell Rep. 11:1847–1855. 2015. View Article : Google Scholar : PubMed/NCBI
|
8
|
Fu PY, Hu B, Ma XL, Tang WG, Yang ZF, Sun
HX, Yu MC, Huang A, Hu JW, Zhou CH, et al: Far upstream
element-binding protein 1 facilitates hepatocellular carcinoma
invasion and metastasis. Carcinogenesis. 41:950–960. 2020.
View Article : Google Scholar
|
9
|
Baumgarten P, Harter PN, Tonjes M, Capper
D, Blank AE, Sahm F, von Deimling A, Kolluru V, Schwamb B,
Rabenhorst U, et al: Loss of FUBP1 expression in gliomas predicts
FUBP1 mutation and is associated with oligodendroglial
differentiation, IDH1 mutation and 1p/19q loss of heterozygosity.
Neuropathol Appl Neurobiol. 40:205–216. 2014. View Article : Google Scholar
|
10
|
Jiang P, Huang M, Qi W, Wang F, Yang T,
Gao T, Luo C, Deng J, Yang Z, Zhou T, et al: FUBP1 promotes
neuroblastoma proliferation via enhancing glycolysis-a new possible
marker of malignancy for neuroblastoma. J Exp Clin Cancer Res.
38:4002019. View Article : Google Scholar : PubMed/NCBI
|
11
|
Duan J, Bao X, Ma X, Zhang Y, Ni D, Wang
H, Zhang F, Du Q, Fan Y, Chen J, et al: Upregulation of far
upstream element-binding protein 1 (FUBP1) promotes tumor
proliferation and tumorigenesis of clear cell renal cell carcinoma.
PLoS One. 12:e01698522017. View Article : Google Scholar : PubMed/NCBI
|
12
|
Muller B, Bovet M, Yin Y, Stichel D, Malz
M, González-Vallinas M, Middleton A, Ehemann V, Schmitt J, Muley T,
et al: Concomitant expression of far upstream element (FUSE)
binding protein (FBP) interacting repressor (FIR) and its splice
variants induce migration and invasion of non-small cell lung
cancer (NSCLC) cells. J Pathol. 237:390–401. 2015. View Article : Google Scholar : PubMed/NCBI
|
13
|
Chen Y, Liu J, Geng N and Feng C:
Upregulation of far upstream element-binding protein 1 (FUBP1)
promotes tumor proliferation and unfavorable prognosis in tongue
squamous cell carcinoma. Int J Biol Markers. 35:56–65. 2020.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Yang L, Zhu JY, Zhang JG, Bao BJ, Guan CQ,
Yang XJ, Liu YH, Huang YJ, Ni RZ and Ji LL: Far upstream
element-binding protein 1 (FUBP1) is a potential c-Myc regulator in
esophageal squamous cell carcinoma (ESCC) and its expression
promotes ESCC progression. Tumour Biol. 37:4115–4126. 2016.
View Article : Google Scholar
|
15
|
Venturutti L, Cordo Russo RI, Rivas MA,
Mercogliano MF, Izzo F, Oakley RH, Pereyra MG, De Martino M,
Proietti CJ, Yankilevich P, et al: MiR-16 mediates trastuzumab and
lapatinib response in ErbB-2-positive breast and gastric cancer via
its novel targets CCNJ and FUBP1. Oncogene. 35:6189–6202. 2016.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Zhang F, Tian Q and Wang Y: Far upstream
element-binding protein 1 (FUBP1) is overexpressed in human gastric
cancer tissue compared to non-cancerous tissue. Onkologie.
36:650–655. 2013. View Article : Google Scholar : PubMed/NCBI
|
17
|
Jia MY and Wang YJ: Far upstream
element-binding protein 1 (FUBP1) expression differs between human
colorectal cancer and non-cancerous tissue. Neoplasma. 61:533–540.
2014. View Article : Google Scholar
|
18
|
Fan P, Ma J and Jin X: Far upstream
element-binding protein 1 is up-regulated in pancreatic cancer and
modulates immune response by increasing programmed death ligand 1.
Biochem Biophys Res Commun. 505:830–836. 2018. View Article : Google Scholar : PubMed/NCBI
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
20
|
Goldman MJ, Craft B, Hastie M, Repečka K,
McDade F, Kamath A, Banerjee A, Luo Y, Rogers D, Brooks AN, et al:
Visualizing and interpreting cancer genomics data via the Xena
platform. Nat Biotechnol. 38:675–678. 2020. View Article : Google Scholar : PubMed/NCBI
|
21
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
StarBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42:D92–97. 2014. View Article : Google Scholar
|
22
|
van Staalduinen J, Baker D, Ten Dijke P
and van Dam H: Epithelial-mesenchymal-transition-inducing
transcription factors: New targets for tackling chemoresistance in
cancer? Oncogene. 37:6195–6211. 2018. View Article : Google Scholar : PubMed/NCBI
|
23
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
24
|
Zhang X, Feng W, Zhang J, Ge L, Zhang Y,
Jiang X, Peng W, Wang D, Gong A and Xu M: Long noncoding RNA PVT1
promotes epithelialmesenchymal transition via the TGFβ/Smad pathway
in pancreatic cancer cells. Oncol Rep. 40:1093–1102.
2018.PubMed/NCBI
|
25
|
Zhao L, Liu S, Che X, Hou K, Ma Y, Li C,
Wen T, Fan Y, Hu X, Liu Y and Qu X: Bufalin inhibits TGF-β-induced
epithelial-to-mesenchymal transition and migration in human lung
cancer A549 cells by downregulating TGF-β receptors. Int J Mol Med.
36:645–652. 2015. View Article : Google Scholar : PubMed/NCBI
|
26
|
Park JH, Yoon J, Lee KY and Park B:
Effects of geniposide on hepatocytes undergoing
epithelial-mesenchymal transition in hepatic fibrosis by targeting
TGFβ/Smad and ERK-MAPK signaling pathways. Biochimie. 113:26–34.
2015. View Article : Google Scholar : PubMed/NCBI
|
27
|
Valcourt U, Kowanetz M, Niimi H, Heldin CH
and Moustakas A: TGF-beta and the Smad signaling pathway support
transcriptomic reprogramming during epithelial-mesenchymal cell
transition. Mol Biol Cell. 16:1987–2002. 2005. View Article : Google Scholar : PubMed/NCBI
|